Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on Wednesday, August 5 to provide a corporate update and discuss its financial ...

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced it ...

Punjab, launched a district-wide School Health Programme in Sangrur to create awareness among adolescents about cancer ...

Nigeria must urgently embrace data-driven agriculture if it hopes to transform farming into a profitable business, strengthen ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of plozasiran in patients with severe hypertriglyceridemia ...

Dr. Rod J. Rohrich, a board-certified plastic surgeon and internationally recognized rhinoplasty expert, has been selected as the 2026 recipient of the Jacques Joseph Award by The Rhinoplasty Society.

Vivoryon Therapeutics N.V. to Report H1 2026 Financial Resultsand Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026 Halle (Saale) / Munich, Germany, July 22, ...

CNN is honoring people who have shoved conventional wisdom aside and are shaping the world around us with their insights and innovations.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the ...

AYA cancer patients with sarcoma may not know resources, including palliative care, are available, and may resist them when ...